ALNY

Alnylam Pharmaceuticals (ALNY)

About Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Details

Daily high

$342.23

Daily low

$331.02

Price at open

$342.00

52 Week High

$495.55

52 Week Low

$225.84

Market cap

45.0B

Dividend yield

0.00%

Volume

413,479

Avg. volume

1.1M

P/E ratio

150.37

Alnylam Pharmaceuticals News